{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-056901","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.324842+00:00","generated_at":"2026-05-18T22:57:52.714382+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Incannex appoints Dr. Kirsch to OSA board; Phase 2 data due July 2025","bullets":["Appointed Douglas B. Kirsch, M.D., FAAN, FAASM to IHL-42X Obstructive Sleep Apnea Clinical Advisory Board.","Dr. Kirsch is Medical Director of Atrium Health Sleep Medicine and former President of the American Academy of Sleep Medicine.","Company expects to report topline Phase 2 data from the U.S. RePOSA study in July 2025.","Phase 3 initiation for IHL-42X targeted for later in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-056901","json":"https://secwatch.observer/filing/0001213900-25-056901.json","markdown":"https://secwatch.observer/filing/0001213900-25-056901.md","text":"https://secwatch.observer/filing/0001213900-25-056901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025056901/0001213900-25-056901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025056901/ea0246656-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:57:52.714382+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}